# Opioid Analgesia for MAB

> **NCT03139240** · PHASE4 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 172 (actual)

## Conditions studied

- MAB
- Pain

## Interventions

- **DRUG:** Oxycodone 10mg oral
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03139240
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-05-31
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2019-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03139240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03139240, "Opioid Analgesia for MAB". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03139240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*